HESTER BIOSCIENCES
|
The Current P/E Ratio of HESTER BIOSCIENCES is 52.93.
Share Price | ₹1,893.5 | Feb 04,2025 |
Market Cap | ₹1,609.5 Cr | |
Earnings-TTM | ₹30.4 Cr | TTM-Consolidated Results |
Price/Earnings | 52.93x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of HESTER BIOSCIENCES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,609.5 Cr] as on Feb 04,2025
(/) Earnings [ ₹30.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 52.93x ]
Thus, for HESTER BIOSCIENCES , the investors are currently willing to pay 52.93 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of HESTER BIOSCIENCES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of HESTER BIOSCIENCES over the last five years.
Historical PE (Price/Earnings) ratio chart of HESTER BIOSCIENCES
PE Ratio Performance Analysis for HESTER BIOSCIENCES
- HESTER BIOSCIENCES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 48.85x.
- HESTER BIOSCIENCES 's operated at median p/e ratio of 48.58x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, HESTER BIOSCIENCES 's p/e ratio peaked in Mar2024 at 62.57x.
- HESTER BIOSCIENCES 's p/e ratio hit its five-year low in Mar2020 of 26.98x.
How does HESTER BIOSCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
HESTER BIOSCIENCES | 30.41 | 52.93 | 1,609.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 36.91 | 423,974.0 |
CIPLA LTD | 5,000.43 | 23.40 | 116,999.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.75 | 101,771.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.79 | 97,951.9 |
DIVIS LABORATORIES LTD | 2,067.00 | 78.24 | 161,729.0 |
MANKIND PHARMA LTD | 2,050.73 | 51.33 | 105,258.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 56.44 | 105,089.0 |
LUPIN LTD | 2,651.94 | 36.33 | 96,354.0 |
AUROBINDO PHARMA LTD | 3,598.83 | 18.90 | 68,023.5 |
ABBOTT INDIA LTD | 1,284.66 | 43.24 | 55,551.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs HESTER BIOSCIENCES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.75x |
Max industry PE | 78.24x |
Median industry PE | 36.91x |
Average industry PE | 39.93x |
You may also like the below Video Courses